NICE releases guidelines on acute kidney injury

Published On 2020-01-10 13:30 GMT   |   Update On 2020-01-10 13:30 GMT

National Institute for health and care excellence has released guidelines for diagnosis and management of acute kidney injury. This guideline covers preventing, detecting and managing acute kidney injury in children, young people and adults.


Major recommendations are-

Preventing acute kidney injury






Ongoing assessment of the condition of people in hospital


1. Follow the recommendations in the NICE guideline on acutely ill adults in hospital on the use of track and trigger systems (early warning scores) to identify adults who are at risk of acute kidney injury because their clinical condition is deteriorating or is at risk of deteriorating. [2013]


2. When adults are at risk of acute kidney injury, ensure that systems are in place to recognise and respond to oliguria (urine output less than 0.5 ml/kg/hour) if the track and trigger system (early warning score) does not monitor urine output. [2013]


3. Consider using a paediatric early warning score to identify children and young people admitted to hospital who are at risk of acute kidney injury because their clinical condition is deteriorating or is at risk of deteriorating.





  • Record physiological observations at admission and then according to local protocols for given paediatric early warning scores.

  • Increase the frequency of observations if abnormal physiology is detected. [2013]



4. If using a paediatric early warning score, use one with multiple‑parameter or aggregate weighted scoring systems that allow a graded response and:





  • define the parameters to be measured and the frequency of observations

  • include a clear and explicit statement of the parameters, cut‑off points or scores that should trigger a response. [2013]



5. If using a paediatric early warning score, use one with multiple‑parameter or aggregate weighted scoring systems that measure:





  • heart rate

  • respiratory rate

  • systolic blood pressure

  • level of consciousness

  • oxygen saturation

  • temperature

  • capillary refill time. [2013]



6. When children and young people are at risk of acute kidney injury because of risk factors in recommendation 1.1.2:





  • measure urine output

  • record weight twice daily to determine fluid balance

  • measure urea, creatinine and electrolytes

  • think about measuring lactate, blood glucose and blood gases. [2013]





Preventing acute kidney injury in adults having iodine-based contrast media


7. Encourage oral hydration before and after procedures using intravenous iodine-based contrast media in adults at increased risk of contrast-induced acute kidney injury (see recommendation 1.1.6). [2019]


8. For inpatients having iodine-based contrast media, consider intravenous volume expansion with either isotonic sodium bicarbonate or 0.9% sodium chloride if they are at particularly high risk, for example, if:





  • they have an eGFR less than 30 ml/min/1.73 m2

  • they have had a renal transplant

  • a large volume of contrast medium is being used (for example, higher than the standard diagnostic dose or repeat administration within 24 hours)

  • intra-arterial administration of contrast medium with first-pass renal exposure is being used.For more information on managing intravenous fluid therapy, see the NICE guideline on intravenous fluid therapy in adults in hospital. [2019]



9. Consider temporarily stopping ACE inhibitors and ARBs in adults having iodine-based contrast media if they have chronic kidney disease with an eGFR less than 40 ml/min/1.73 m2. [2013]


10. Discuss the person's care with a nephrology team before offering iodine-based contrast media to adults on renal replacement therapy, including people with a renal transplant, but do not delay emergency imaging for this. [2019]





Monitoring and preventing deterioration in people with or at high risk of acute kidney injury


11. Consider electronic clinical decision support systems (CDSS) to support clinical decision making and prescribing, but ensure they do not replace clinical judgement. [2013]


12. When acquiring any new CDSS or systems for electronic prescribing, ensure that any systems considered:





  • can interact with laboratory systems

  • can recommend drug dosing and frequency

  • can store and update data on patient history and characteristics, including age, weight and renal replacement therapy

  • can include alerts that are mandatory for the healthcare professional to acknowledge and review. [2013]



13. Seek advice from a pharmacist about optimising medicines and drug dosing in adults, children and young people with or at risk of acute kidney injury. [2013]


14. Consider temporarily stopping ACE inhibitors and ARBs in adults, children and young people with diarrhoea, vomiting or sepsis until their clinical condition has improved and stabilised. [2013]






Detecting acute kidney injury




  1. Detect acute kidney injury, in line with the (p)RIFLE, AKIN or KDIGO definitions, by using any of the following criteria:




  • a rise in serum creatinine of 26 micromol/litre or greater within 48 hours

  • a 50% or greater rise in serum creatinine known or presumed to have occurred within the past 7 days

  • a fall in urine output to less than 0.5 ml/kg/hour for more than 6 hours in adults and more than 8 hours in children and young people

  • a 25% or greater fall in eGFR in children and young people within the past 7 days. [2013]



2.Monitor serum creatinine regularly in all adults, children and young people with or at risk of acute kidney injury. [2013]





Identifying the cause(s) of acute kidney injury


1. Identify the cause(s) of acute kidney injury and record the details in the person's notes. [2013]




Urinalysis


2. Perform urine dipstick testing for blood, protein, leukocytes, nitrites and glucose in all people as soon as acute kidney injury is suspected or detected. Document the results and ensure that appropriate action is taken when results are abnormal. [2013]


3. Think about a diagnosis of acute nephritis and referral to the nephrology team when an adult, child or young person with no obvious cause of acute kidney injury has urine dipstick results showing haematuria and proteinuria, without urinary tract infection or trauma due to catheterisation. [2013]





Ultrasound


4. Do not routinely offer ultrasound of the urinary tract when the cause of the acute kidney injury has been identified. [2013]


5. When pyonephrosis (infected and obstructed kidney[s]) is suspected in adults, children and young people with acute kidney injury, offer immediate ultrasound of the urinary tract (to be performed within 6 hours of assessment). [2013]


6. When adults, children and young people have no identified cause of their acute kidney injury or are at risk of urinary tract obstruction, offer urgent ultrasound of the urinary tract (to be performed within 24 hours of assessment). [2013]






Managing acute kidney injury




Relieving urological obstruction


1. Refer all adults, children and young people with upper tract urological obstruction to a urologist. Refer immediately when one or more of the following is present:





  • pyonephrosis

  • an obstructed solitary kidney

  • bilateral upper urinary tract obstruction

  • complications of acute kidney injury caused by urological obstruction. [2013]



2. When nephrostomy or stenting is used to treat upper tract urological obstruction in adults, children and young people with acute kidney injury, carry it out as soon as possible and within 12 hours of diagnosis. [2013]





Pharmacological management


3. Do not routinely offer loop diuretics to treat acute kidney injury. [2013]


4. Consider loop diuretics for treating fluid overload or oedema while:





  • an adult, child or young person is awaiting renal replacement therapy or

  • renal function is recovering in an adult, child or young person not receiving renal replacement therapy. [2013]



5. Do not offer low-dose dopamine to treat acute kidney injury. [2013]





Referring for renal replacement therapy


6. Discuss any potential indications for renal replacement therapy with a nephrologist, paediatric nephrologist and/or critical care specialist immediately to ensure that the therapy is started as soon as needed. [2013]


7. When an adult, child or young person has significant comorbidities, discuss with them and/or their parent or carer and within the multidisciplinary team whether renal replacement therapy would offer benefit. Follow the recommendations on shared decision making in the NICE guideline on patient experience in adult NHS services. [2013]


8. Refer adults, children and young people immediately for renal replacement therapy if any of the following are not responding to medical management:





  • hyperkalaemia

  • metabolic acidosis

  • symptoms or complications of uraemia (for example, pericarditis or encephalopathy)

  • fluid overload

  • pulmonary oedema. [2013]



9. Base the decision to start renal replacement therapy on the condition of the adult, child or young person as a whole and not on an isolated urea, creatinine or potassium value. [2013]


10. When there are indications for renal replacement therapy, the nephrologist and/or critical care specialist should discuss the treatment with the adult, child or young person and/or their parent or carer as soon as possible and before starting treatment. Follow the recommendations on shared decision making in the NICE guideline on patient experience in adult NHS services. [2013]





Referring to nephrology


11. Refer adults, children and young people with acute kidney injury to a nephrologist, paediatric nephrologist or critical care specialist immediately if they meet criteria for renal replacement therapy in recommendation 8. [2013]


12. Do not refer adults, children or young people to a nephrologist or paediatric nephrologist when there is a clear cause for acute kidney injury and the condition is responding promptly to medical management, unless they have a renal transplant. [2013]


13. Consider discussing management with a nephrologist or paediatric nephrologist when an adult, child or young person with severe illness might benefit from treatment, but there is uncertainty as to whether they are nearing the end of their life. [2013]


14. Refer adults, children and young people in intensive care to a nephrology team when there is uncertainty about the cause of acute kidney injury or when specialist management of kidney injury might be needed. [2013]


15. Discuss the management of acute kidney injury with a nephrologist or paediatric nephrologist as soon as possible and within 24 hours of detection when one or more of the following is present:





  • a possible diagnosis that may need specialist treatment (for example, vasculitis, glomerulonephritis, tubulointerstitial nephritis or myeloma)

  • acute kidney injury with no clear cause

  • inadequate response to treatment

  • complications associated with acute kidney injury

  • stage 3 acute kidney injury (according to (p)RIFLE, AKIN or KDIGO criteria)

  • a renal transplant

  • chronic kidney disease stage 4 or 5. [2013]



16. Monitor serum creatinine after an episode of acute kidney injury. Consider referral to a nephrologist or paediatric nephrologist when eGFR is 30 ml/min/1.73 m2 or less in adults, children and young people who have recovered from an acute kidney injury. [2013]


17. Consider referral to a paediatric nephrologist for children and young people who have recovered from an episode of acute kidney injury but have hypertension, impaired renal function or 1+ or greater proteinuria on dipstick testing of an early morning urine sample. [2013]







For further reference log on to : https://www.nice.org.uk/guidance/NG148






Article Source : National Institute for health and care excellence

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

NICE Guidelines on Latent TB